Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liposomal Encapsulation of Tartar Emetic Improves Pharmacokinetic Profile and Mitigates Cardiotoxicity in Murine Experimental Model.

Pharmaceutics·2025
Same author

Evaluation of the Antitumor Effectiveness and Toxicity of pH-Sensitive Liposomes Coencapsulating Doxorubicin and Simvastatin in a Murine Breast Cancer Model.

ACS omega·2025
Same author

Benefits of Dietary Supplementation with Specific Silicon-Enriched Spirulina on Arterial Function in Healthy Elderly Individuals: A Randomized, Placebo-Controlled Trial.

Nutrients·2025
Same author

<i>Nkx2-5</i> Loss of Function in the His-Purkinje System Hampers Its Maturation and Leads to Mechanical Dysfunction.

Journal of cardiovascular development and disease·2023
Same author

Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.

AAPS PharmSciTech·2023
Same author

Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model.

Journal of personalized medicine·2023
Same journal

Epigenetic plasticity and chemoresistance in cancer: mechanisms, biomarkers, and translational opportunities for real-world evidence.

Frontiers in cell and developmental biology·2026
Same journal

Matched embryo-endometrium RNA-seq reveals coordinated but asymmetric transcriptomic reprogramming at the onset of early equine pregnancy.

Frontiers in cell and developmental biology·2026
Same journal

Myelin development in the peripheral nervous system of <i>Trachemys scripta</i>.

Frontiers in cell and developmental biology·2026
Same journal

A deep learning-based classification method for subclinical zonular laxity in AS-OCT images.

Frontiers in cell and developmental biology·2026
Same journal

Advancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies.

Frontiers in cell and developmental biology·2026
Same journal

CRISPR-based next-generation molecular diagnostics for bone infection.

Frontiers in cell and developmental biology·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Stimulating endogenous cardiac repair.

Amanda Finan1, Sylvain Richard1

  • 1Centre National de la Recherche Scientifique United Medical Resource 9214, Institut National de la Santé et de la Recherche Médicale U1046, Physiology and Experimental Medicine of the Heart and Muscles, University of Montpellier Montpellier, France.

Frontiers in Cell and Developmental Biology
|October 21, 2015
PubMed
Summary
This summary is machine-generated.

Cardiac regeneration involves cardiac progenitor cells and bone marrow stem cells, but their potential is limited. Augmenting natural repair pathways through cell, gene, or drug therapy offers promising strategies for heart healing.

Keywords:
beta blockerscardiac progenitor cellscell therapygene therapyregenerationstatinsstem cells

More Related Videos

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.2K
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

20.1K

Related Experiment Videos

Last Updated: Mar 31, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.2K
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

20.1K

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Stem Cell Research

Background:

  • The adult heart exhibits limited cardiomyocyte turnover, but regeneration capacity increases post-injury.
  • Cardiac regeneration involves resident cardiac progenitor cells and circulating stem cells, including bone marrow-derived populations.
  • While essential for repair, endogenous stem cells have limited potential for complete cardiac regeneration.

Purpose of the Study:

  • To review current strategies for augmenting cardiac regeneration after injury.
  • To explore the roles of cell therapy, gene therapy, and pharmacological interventions in enhancing myocardial repair.
  • To discuss the potential of combining approaches for improved cardiac healing.

Main Methods:

  • Review of existing literature on cardiac regeneration mechanisms and therapeutic interventions.
  • Analysis of studies investigating the contribution of cardiac progenitor cells and bone marrow stem cells to cardiac repair.
  • Evaluation of cell therapy, gene therapy, and pharmacological approaches for their impact on endogenous stem cell activity and myocardial healing.

Main Results:

  • Cell therapy shows modest benefits, primarily through paracrine effects and recruitment of endogenous stem cells, not direct regeneration.
  • Gene therapy targeting natural signaling pathways activates endogenous stem cells, showing positive preclinical and clinical trial results.
  • Pharmacological agents like statins and beta-blockers may influence endogenous stem cell activity, suggesting potential for refining existing treatments.

Conclusions:

  • Current therapeutic strategies aim to enhance the heart's natural regenerative capacity.
  • Combining cell, gene, and pharmacological therapies holds promise for maximizing endogenous cardiac regeneration.
  • Further research is needed to optimize these approaches for comprehensive myocardial repair.